glp-1 dietitian The Hub 💉 GLP-1 meds don't just

The GLP-1 Analogues Market estimated size and share is projected to exceed USD 322.85 Billion by 2034, with a forecasted CAGR of 21.3% during the period.

1, a powerful probiotic enhanced formula with 1 billion CFU designed to optimize GLP-1 levels for maximum weight loss, promote gut health, and alleviate IBS symptoms like diarrhea, constipation, and abdominal pain

Featuring a powerful GLP-1 formula, this product is perfect for those looking to maintain overall well-being

Getting Enough Protein Protein helps support muscle maintenance, recovery, and overall health

Beyond these frontrunners, the pipeline is expanding: Novo Nordisk filed for FDA approval of CagriSema in 2025, the first once-weekly combination of GLP1 and amylin analogue